CSPHF
Price
$0.23
Change
+$0.03 (+15.00%)
Updated
Nov 22 closing price
LIPO
Price
$2.64
Change
-$0.12 (-4.35%)
Updated
Dec 18, 04:58 PM (EDT)
70 days until earnings call
Ad is loading...

CSPHF vs LIPO

Header iconCSPHF vs LIPO Comparison
Open Charts CSPHF vs LIPOBanner chart's image
CSTONE PHARMACEUTICALS
Price$0.23
Change+$0.03 (+15.00%)
Volume$5.8K
CapitalizationN/A
Lipella Pharmaceuticals
Price$2.64
Change-$0.12 (-4.35%)
Volume$500
CapitalizationN/A
CSPHF vs LIPO Comparison Chart
Loading...
LIPO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CSPHF vs. LIPO commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSPHF is a Hold and LIPO is a Buy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (CSPHF: $0.23 vs. LIPO: $2.76)
Brand notoriety: CSPHF and LIPO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CSPHF: 2% vs. LIPO: 19%
Market capitalization -- CSPHF: $437.98M vs. LIPO: $3.34M
CSPHF [@Biotechnology] is valued at $437.98M. LIPO’s [@Biotechnology] market capitalization is $3.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSPHF’s FA Score shows that 0 FA rating(s) are green whileLIPO’s FA Score has 0 green FA rating(s).

  • CSPHF’s FA Score: 0 green, 5 red.
  • LIPO’s FA Score: 0 green, 5 red.
According to our system of comparison, CSPHF is a better buy in the long-term than LIPO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LIPO’s TA Score shows that 4 TA indicator(s) are bullish.

  • LIPO’s TA Score: 4 bullish, 3 bearish.

Price Growth

CSPHF (@Biotechnology) experienced а 0.00% price change this week, while LIPO (@Biotechnology) price change was -7.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.91%, and the average quarterly price growth was -1.42%.

Reported Earning Dates

LIPO is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSPHF($438M) has a higher market cap than LIPO($3.34M). CSPHF YTD gains are higher at: -29.751 vs. LIPO (-66.176).
CSPHFLIPOCSPHF / LIPO
Capitalization438M3.34M13,126%
EBITDAN/AN/A-
Gain YTD-29.751-66.17645%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/A93.7K-
TECHNICAL ANALYSIS
Technical Analysis
LIPO
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
LIPO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

CSPHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSPHF has been loosely correlated with DVHGF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CSPHF jumps, then DVHGF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSPHF
1D Price
Change %
CSPHF100%
N/A
DVHGF - CSPHF
38%
Loosely correlated
N/A
KMSTF - CSPHF
35%
Loosely correlated
N/A
IRON - CSPHF
32%
Poorly correlated
-1.78%
LIPO - CSPHF
30%
Poorly correlated
+2.22%
CDMO - CSPHF
24%
Poorly correlated
N/A
More

LIPO and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIPO has been loosely correlated with DVHGF. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if LIPO jumps, then DVHGF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIPO
1D Price
Change %
LIPO100%
+2.22%
DVHGF - LIPO
44%
Loosely correlated
N/A
KMSTF - LIPO
41%
Loosely correlated
N/A
CSPHF - LIPO
30%
Poorly correlated
N/A
ATXI - LIPO
22%
Poorly correlated
-4.60%
BLPH - LIPO
22%
Poorly correlated
N/A
More